The AML1-ETO, CBFB-MYH11, and PML-RARA oncofusion protein associated AML-subtypes each account for 5%-10% of all AML cases while FUS-ERG fusions are relatively rare (<1%). The gene discussed is FUS; the disease is acute myeloid leukemia.